Valuation: CStone Pharmaceuticals

Market Cap 7.01B 8.19B 1.04B 919M 869M 788M 1.48B 100B 1.49B 10.4B 4.02B 51.16B 3.92B 3.84B 164B P/E 2026 *
-15.2x
P/E 2027 * 4.11x
Enterprise Value 6.03B 7.05B 899M 791M 748M 678M 1.27B 86.28B 1.28B 8.95B 3.46B 44.03B 3.37B 3.3B 141B EV / Sales 2026 *
14.3x
EV / Sales 2027 * 1.74x
Free-Float
79.87%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+8.17%
1 week-2.28%
Current month-3.30%
1 month-3.30%
3 months+13.93%
6 months-36.46%
Current year+5.50%
1 week 5.04
Extreme 5.04
5.88
1 month 5.04
Extreme 5.04
6.58
Current year 4.01
Extreme 4.01
10.41
1 year 4.01
Extreme 4.01
10.41
3 years 0.8
Extreme 0.8
13.15
5 years 0.8
Extreme 0.8
13.15
10 years 0.8
Extreme 0.8
19.12
Manager TitleAgeSince
Chief Executive Officer 62 2022-08-24
Director of Finance/CFO - 2023-01-17
Chief Operating Officer 46 2016-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 2022-08-24
Director/Board Member 63 2021-07-08
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 Other

Chief Executive Officer

291,500 0.0182%
9/18/26 Other

Chief Executive Officer

72,000 0.0045%
9/17/26 Other

Chief Executive Officer

132,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+8.17%-2.28%-28.07%+200.54% 1.04B
-0.80%+14.07%+705.55%+96.75% 78.76B
-4.54%-5.75%+33.40%-9.86% 75.12B
+0.21%+0.87%-8.39%-27.31% 61.14B
+0.56%+0.23%-5.98%+175.99% 46.07B
+2.49%-0.14%-8.95%+33.71% 47.57B
+0.48%+4.39%+66.48%-11.30% 33.79B
+0.75%+0.14%+50.93%+112.97% 25.3B
-0.21%-6.98%+2.46%+150.72% 21.34B
+0.77%-1.34%+58.27%+97.94% 15.36B
Average +0.87%-0.09%+86.57%+82.01% 40.55B
Weighted average by Cap. -0.29%+2.00%+151.22%+55.06%

Financials

2026 *2027 *
Net sales 423M 494M 63.03M 55.43M 52.42M 47.54M 89.29M 6.05B 89.81M 628M 242M 3.09B 237M 232M 9.92B 1.72B 2.01B 257M 226M 213M 194M 363M 24.62B 366M 2.55B 987M 12.56B 963M 942M 40.38B
Net income -384M -448M -57.13M -50.24M -47.51M -43.09M -80.93M -5.48B -81.4M -569M -220M -2.8B -214M -210M -8.99B 680M 795M 101M 89.14M 84.29M 76.45M 144M 9.73B 144M 1.01B 390M 4.96B 381M 372M 15.95B
Net Debt -978M -1.14B -146M -128M -121M -110M -206M -13.98B -207M -1.45B -560M -7.13B -547M -535M -22.92B -4.02B -4.7B -599M -527M -498M -452M -849M -57.52B -854M -5.97B -2.3B -29.35B -2.25B -2.2B -94.31B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
102
Date Price Change Volume
26-09-29 HK$5.560 +8.17% 8,736,000
26-09-28 HK$5.140 -3.66% 7,553,000
26-09-25 HK$5.335 -0.74% 1,732,500
26-09-24 HK$5.375 -7.01% 7,806,000
26-09-23 HK$5.780 +1.58% 5,608,848
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.399CNY
Average target price
12.36CNY
Spread / Average Target
+181.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2616 Stock